Evaluation of prophylactic granulocyte colony-stimulating factor before chemotherapy on children's with malignant neuroblastoma
Not Applicable
- Conditions
- malignant noroblastoma.Adrenal gland, unspecified
- Registration Number
- IRCT2014050717610N1
- Lead Sponsor
- Vice Chancellor for research of Tabriz University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 50
Inclusion Criteria
pathologically confirmed neuroblastoma; age below 16 years; stage 3 and 4 of disease; normal cell counts before each cycle of chemotherapy; absolute neutrophil count above 1000 and platelet count above 100000 per cubic microliter
Exclusion Criteria
previous history of receiving granulocyte colony stimulating factor
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Increased numbers of neutrophils. Timepoint: 3 days. Method of measurement: Complete blood count.
- Secondary Outcome Measures
Name Time Method